-
CLVSQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Clovis Oncology (CLVSQ)
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 58.32 mm | 58.32 mm | 58.32 mm | 58.32 mm | 58.32 mm | 58.32 mm |
Cash burn (monthly) | 12.09 mm | 9.47 mm | 18.66 mm | 21.03 mm | 13.54 mm | 14.63 mm |
Cash used (since last report) | 351.49 mm | 275.38 mm | 542.66 mm | 611.47 mm | 393.67 mm | 425.51 mm |
Cash remaining | -293.17 mm | -217.06 mm | -484.34 mm | -553.15 mm | -335.35 mm | -367.19 mm |
Runway (months of cash) | -24.3 | -22.9 | -26.0 | -26.3 | -24.8 | -25.1 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 10.67 mm |
Total shares | 2.96 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
D. E. Shaw & Co | 2.96 mm | $10.67 mm |